Cas No.: 58100-03-1
PRODUCT INFORMATION
Description
Tyr-Somatostatin-14 (Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys) is a custom-synthesized peptide variant of Somatostatin-14. It has been modified with an additional N-terminal Tyrosine residue. This tyrosine provides a site for radiolabeling (e.g., with Iodine-125) or other chemical modifications, making it a useful tracer for in vitro receptor-binding assays.
Molecular Weight
1801.05
Purity
> 95%
Formula
C₈₅H₁₁₃N₁₉O₂₁S₂
Product Type
Targeting Peptide
Sequence
Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge: Cys4-Cys15)
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- FRα-targeting Peptide C7 (CAT#: OLY-1025-YS-13)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.